FDA Recall Open, Classified

ARIES SARS-CoV-2 Assay, REF: 50-10047

Recall: Z-0134-2023 · Initiated September 14, 2022

Recall

Recall Number
Z-0134-2023
Event Number
90937
Firm
Luminex Corporation
FEI Number
3002524000
Product Code
QJR
Status
Open, Classified
Root Cause
Packaging process control
Initiated
September 14, 2022
Posted
October 26, 2022
Address
12212 Technology Blvd, Austin, TX, 78727-6101

Description

ARIES SARS-CoV-2 Assay, REF: 50-10047

Reason

A part defect with the wash 1 syringe of an SARS-CoV-2 assay could lead to incomplete extraction thereby producing an invalid or false negative assay result.

Action

On 09/14/22, recall notices were emailed to customers who were asked to do the following: 1. Cease all use, and isolate or quarantine affected devices pending disposal. 2. If affected devices are identified, contact the recalling firm at [email protected] to arrange for replacement and confirm the disposal of any remaining kits in your inventory per the package insert disposal guidelines. 3. Perform a retrospective review of results obtained using the affected SARS-CoV-2 Assay. If you suspect that you have encountered a false negative result with a patient sample, please contact the recalling firm at [email protected]. 4. Distribute the notification to any individuals within your organization who need to be made aware of this recall. 5. If affected devices were further distributed, notify your customers of this recall. 6. Please complete and return the Acknowledgement & Receipt Form. 7. For those with complaints, questions, or concerns, please contact Global Technical Support Services at 1-877-785-2323 (U.S. and Canada) or +1-512-381 -4397 (Outside U.S. and Canada). On 12/05/22, additional recall notices were sent to customers notifying them that two additional lots were impacted.

Distribution

Distribution US nationwide, Indonesia, and Hong Kong.

Quantity

5,141 (24 Cassettes)